CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Comfilcon A lens (test) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03417557
NCT03417557N/ACompleted
CompareCT.gov

Clinical Validation Study of Biofinity Multifocal Toric Contact Lenses

CooperVision, Inc.·interventional·Posted Jan 31, 2018·Updated May 4, 2020

In Brief

A clinical study evaluating Comfilcon A lens (test) and Omafilcon B lens (control) for Presbyopia. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This is a study to evaluate the clinical performance and subjective acceptance of an investigational contact lens (test), compared to a marketed lens (control) in an in-office setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 31, 2018
Enrollment StartJan 12, 2018
Primary CompletionApr 3, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 8.4 years ago

Interventions

Comfilcon A lens (test)device

contact lens

Omafilcon B lens (control)device

contact lens